ReviewContemporary oncology (Poznan, Poland)2014

Genetic and immune factors underlying the efficacy of cetuximab and panitumumab in the treatment of patients with metastatic colorectal cancer.

Paweł Adam Krawczyk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.